Filing Details
- Accession Number:
- 0001562180-25-004035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-20 16:32:10
- Reporting Period:
- 2025-05-15
- Filing Date:
- 2025-05-20
- Accepted Time:
- 2025-05-20 16:32:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231589 | A Paul Mahon | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Evp & General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-15 | 11,000 | $117.76 | 47,781 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-15 | 2,139 | $293.31 | 45,642 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 1,104 | $293.96 | 44,538 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 5,004 | $295.10 | 39,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 1,744 | $296.41 | 37,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 800 | $297.33 | 36,990 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 4 | $299.00 | 36,986 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 203 | $300.24 | 36,783 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-15 | 2 | $302.02 | 36,781 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-05-15 | 11,000 | $0.00 | 11,000 | $117.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
Footnotes
- This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.
- This transaction was executed in multiple trades at prices ranging from $292.615 to $293.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $293.67 to $294.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $294.77 to $295.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $295.85 to $296.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $297.09 to $298.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $300.20 to $300.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
